Following positive trial findings , retatrutide, a novel peptide therapy for treating type 2 hyperglycemia , has received regulatory approval from Great Britain's Healthcare and Regulatory Agency ( MHRA https://jayawdtb025532.arwebo.com/63536550/retatrutide-compound-peptide-united-kingdom-approval-and-launch